Hugel, Inc.
A biopharmaceutical company developing and distributing medical aesthetic products.
145020 | KO
Overview
Corporate Details
- ISIN(s):
- KR7145020004
- LEI:
- Country:
- South Korea
- Address:
- 강원특별자치도 춘천시 동내면 거두단지1길 23 -, 춘천시
- Website:
- https://www.hugel-inc.com/
- Sector:
- Manufacturing
Description
Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-30 00:00 |
정기주주총회결과
|
Korean | 21.0 KB | ||
| 2023-03-30 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 33.0 KB | ||
| 2023-03-30 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 32.8 KB | ||
| 2023-03-22 00:00 |
[기재정정]투자판단관련주요경영사항('보톡스 의약품을 미승인 판매한 6개 제약사 기소' 검찰 보도 관련사항)
|
Korean | 9.6 KB | ||
| 2023-03-22 00:00 |
감사보고서제출
|
Korean | 24.6 KB | ||
| 2023-03-22 00:00 |
사업보고서 (2022.12)
|
Korean | 1.9 MB | ||
| 2023-03-22 00:00 |
[기재정정]사업보고서 (2022.12)
|
Korean | 1.9 MB | ||
| 2023-03-16 00:00 |
투자판단관련주요경영사항(리도카인 함유 액상 보툴리눔 톡신 제제 "HG102" 임상3상 IND 신청)
|
Korean | 10.7 KB | ||
| 2023-03-15 00:00 |
주주총회소집공고
|
Korean | 356.6 KB | ||
| 2023-03-15 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.8 KB | ||
| 2023-03-15 00:00 |
의결권대리행사권유참고서류
|
Korean | 294.3 KB | ||
| 2023-03-15 00:00 |
투자판단관련주요경영사항('보톡스 의약품을 미승인 판매한 6개 제약사 기소' 검찰 보도 관련사항)
|
Korean | 5.6 KB | ||
| 2023-03-09 00:00 |
주주총회소집결의
|
Korean | 9.5 KB | ||
| 2023-03-09 00:00 |
타법인주식및출자증권취득결정
|
Korean | 26.0 KB | ||
| 2023-03-09 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 26.3 KB |
Automate Your Workflow. Get a real-time feed of all Hugel, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hugel, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hugel, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
